635.22USD-0.57%Mkt Cap: 66.47B USDP/E: 15.48Last update: 2026-05-26
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammator…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
31.10BUSDP/E 28.4
Indicators:|
Key Statistics
Company
Market Cap66.47B USD
Enterprise Value59.33B USD
Revenue (TTM)14.92B USD
Gross Profit12.24B USD
Net Income (TTM)4.50B USD
Revenue/Share143.56 USD
Last Price635.22 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees15.3K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS75886F1075
Valuation
P/E (Trailing)15.48
P/E (Forward)11.95
PEG1.13
EV/EBITDA13.54
EV/Revenue3.98
P/S4.52
P/B2.08
EPS (TTM)40.93
EPS (Forward)53.77
52W Range
476.4946% of range821.11
52W High821.11 USD
52W Low476.49 USD
Profitability
Gross Margin85.35%
Oper. Margin20.66%
EBITDA Margin29.38%
Profit Margin31.41%
ROE14.41%
ROA11.11%
Growth
Revenue Growth19.00%
Earnings Growth-7.20%
Cash Flow & Leverage
Operating CF4.98B USD
CapEx (TTM)1.21B USD
FCF Margin21.94%
FCF Yield4.92%
Net Debt-6.05B USD
Net Debt/EBITDA-1.38
Balance Sheet
Debt/Equity0.09
Current Ratio3.56
Quick Ratio2.84
Book Value/Sh308.32 USD
Cash/Share86.04 USD
Dividends
Fwd Div Rate3.760 USD
Trail. Div Rate3.580 USD
Div. Yield0.59%
5Y Avg Yield—
Payout Ratio8.74%
Ex-Div DateMay 20, 2026
Pay DateJun 4, 2026
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)833.31 USD
Target Range641.00 USD – 1000.00 USD
# Analysts28
Ownership
Shares Out.103.02M
Float97.67M
Insiders2.03%
Institutions92.31%
Short Interest
Short Ratio4.5d
Short % Float3.30%
Short % Out.3.12%
Shares Short3.27M
Short (prev mo.)2.55M
Technical
SMA 50731.64 (-13.2%)
SMA 200692.94 (-8.3%)
Beta0.30
S&P 52W Chg28.31%
Avg Vol (30d)893.69K
Avg Vol (10d)1.18M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—